Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Immunovant (IMVT) Interest Expenses (2019)

Immunovant filings provide 1 years of Interest Expenses readings, the most recent being $376000.0 for Q4 2019.

  • Quarterly Interest Expenses changed N/A to $376000.0 in Q4 2019 from the year-ago period, while the trailing twelve-month figure was $376000.0 through Sep 2020, up 51.0% year-over-year, with the annual reading at $625000.0 for FY2020, N/A changed from the prior year.
  • Interest Expenses hit $376000.0 in Q4 2019 for Immunovant, up from $249000.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $376000.0 in Q4 2019 and bottomed at $249000.0 in Q3 2019.